FDA Adverse Event Injury Summary report: N

TRULIANT TIB IMP CR INS STD SZ 2, 11MM

MDR report key: 18279511 · Received December 6, 2023

Report

Report Number
1038671-2023-02923
Event Type
Injury
Date Received
December 6, 2023
Date of Event
March 21, 2023
Report Date
July 21, 2025
Manufacturer
EXACTECH, INC.
Product Code
JWH
UDI-DI
10885862306289
PMA / PMN Number
K152170
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

(D10) CONCOMITANT DEVICE(S): (B)(6): 02-020-13-0320 - TRULIANT CR CEM FEM CR CEM RIGHT SZ 2. (B)(6): 02-022-45-2020 - TRULIANT TIB FIT TRAY CEM SZ 2F / 2T. (B)(6): 200-07-32 - ADVANCED PATELLA 32MM 3 PEG IMPLANT.

Additional Manufacturer Narrative · 0

THE REASON FOR THE CLINICAL SYMPTOM OF PAIN REPORTED CANNOT BE CONCLUSIVELY DETERMINED AND THE EVENT CANNOT BE CONFIRMED BECAUSE THE DEVICES WERE NOT AVAILABLE FOR EVALUATION, AND RELEVANT PATIENT INFORMATION, IMAGES, OR RADIOGRAPHS WERE NOT PROVIDED. D4: CORRECTED H6: CORRECTED HEALTH EFFECT, COMPONENT, AND INVESTIGATION CLINICAL CODES.

Description of Event or Problem · 0

AS REPORTED BY THE EXACTECH TRULIANT KNEE CLINICAL STUDY, THE 69 YEAR OLD FEMALE PATIENT HAD AN INITIAL RIGHT TKA ON (B)(6) 2017. THE PATIENT PRESENTED ON (B)(6) 2023 WITH TRICOMPARTMENTAL DEGENERATIVE CHANGES WITH LATERAL JOINT SPACE NARROWING, SCLEROSING AND OSTEOPHYTE FORMATION. THE CASE REPORT FORM INDICATES THAT THIS EVENT IS POSSIBLY RELATED TO DEVICE AND DEFINITELY NOT RELATED TO PROCEDURE. OUTCOME IS CONTINUING. PATIENT WAS HAVING DISCOMFORT; PAIN WAS RELATED MORE TO THE JOINT CAPSULE AND NOT THE HARDWARE. PATIENT DECLINED ELECTIVE REVISION SURGERY. TOPICAL ANESTHETIC CREAM WAS PRESCRIBED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
258488 TRULIANT TIB IMP CR INS STD SZ 2, 11MM PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL JWH EXACTECH, INC. UNK 10885862306289

Patients

Seq Age Sex Outcome Treatment
1 69 YR Female